• 2nd Next Generation Sequencing
    for Adventitious Virus Detection
    in Human and Veterinary Biologics

    November 13-14, 2019
    Het Pand, Ghent University,
    Belgium
    Provax IABS
  • Meeting co-organized by

Meeting documents & Info

Presentations

About the Meeting

Objectives of the meeting

This meeting will focus on the current scientific data and knowledge related to the use of next generation sequencing technologies for adventitious virus detection in biological products. Discussions will include ongoing efforts and future needs toward standardization and validation of the technical and bioinformatics steps involved in NGS for its applications in characterization and safety evaluation of biologics, including human and animal vaccines. The meeting will bring together representatives from industry, academia, technology providers, and international regulatory bodies for developing a scientific consensus regarding readiness of NGS for detection of adventitious viruses in biologics.

Scientific committee

Dr. Dieter Deforce, co-Chair
Ghent University
Dr. Sebastiaan Theuns, co-Chair
Ghent University
Dr. Arifa Khan
FDA
Dr. Sven Arnouts
Ghent University / PROVAXS
Dr. Johannes Blümel
Paul-Ehrlich-Institut (PEI)
Dr. William Egan
GlaxoSmithKline
Dr. Matthias Janssen
World Health Organization (WHO)
Dr. Carmen Jungbäck
International Alliance for Biological Standardization (IABS)
Dr. Ivana Knezevic
Word Health Organization (WHO)
Dr. David Mackay
formerlly EMA
Dr. Laurent Mallet
Sanofi Pasteur
Dr. Pieter Neels
International Alliance for Biological Standardization (IABS)
Dr. Gerald G. Schumann
Paul-Ehrlich-Institut (PEI)
Dr. Joseph Victoria
Boehringer-Ingelheim